ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/06/20
ADMA Biologics Reports Business Highlights and Second Quarter 2020 Financial ResultsGlobeNewsWire • 08/05/20
ADMA Biologics to Report Business Highlights and Second Quarter 2020 Financial Results on August 5, 2020GlobeNewsWire • 07/29/20
Are Options Traders Betting on a Big Move in ADMA Biologics (ADMA) Stock?Zacks Investment Research • 06/01/20
ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent AccomplishmentsGlobeNewsWire • 05/07/20
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/07/20
ADMA Biologics: Not Immune To Coronavirus Sell-Off Despite Their Ability To HelpSeeking Alpha • 03/25/20
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/13/20
ADMA Biologics Highlights Expanded Intellectual Property Portfolio for Specialty Plasma Derived Immune Globulins Targeted Against Respiratory InfectionsGlobeNewsWire • 03/03/20
ADMA Biologics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection with Its Public Offering of Common StockGlobeNewsWire • 02/24/20
ADMA Biologics Announces Pricing of Upsized $82.3 Million Public Offering of Common StockGlobeNewsWire • 02/07/20
ADMA Biologics Announces Proposed $75 Million Public Offering of Common StockGlobeNewsWire • 02/06/20